Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03636321
Other study ID # AS.fac.med.55
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 10, 2018
Est. completion date November 10, 2019

Study information

Verified date May 2020
Source Minia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Determination of biliary complications in stented group compared to duct to duct anastomosis without stent


Description:

30 patients included in the study. patients will be randomly allocated in two equal groups. In group A anastomosis will be done on intraductal stent and in group B anastomosis done without stent .the patients will be followed for one year to compare the result of two groups as regard biliary complications.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date November 10, 2019
Est. primary completion date November 10, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- adult patients eligible for a liver transplantation

- patients' written informed consent signed.

Exclusion Criteria:

- biliary reconstruction requires a hepatico-jejunostomy for anatomical/biliary disease reason.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
living donor liver transplantation with internal biliary stent
living donor liver transplantation without internal biliary stent

Locations

Country Name City State
Egypt Air force spcialized hospital Cairo

Sponsors (2)

Lead Sponsor Collaborator
Alaa Mstafa Hassan Sewefy Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Other skeletonization of duct skeletonization of duct 10 hours
Primary biliary complications after living donor liver transplantation incidence of biliary complications after living donor liver transplantation one year
Secondary biliary complications types of biliary complications one year
Secondary biliary related mortality mortality one year
Secondary rate of cholangitis rate of cholangitis 3 months
Secondary hospital stay hospital stay one month
Secondary time 2 biliary complications time 2 biliary complications one year
See also
  Status Clinical Trial Phase
Completed NCT02798861 - Controlled Attenuation Parameter (CAP) in Liver Allografts
Completed NCT03527238 - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine Phase 2
Completed NCT01696331 - Text Messaging for Adherence in Adolescent Liver Transplant Recipients N/A
Recruiting NCT05051605 - Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
Recruiting NCT05940857 - Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry
Completed NCT01598987 - Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. Phase 3
Active, not recruiting NCT05074160 - OCS Liver Perfusion (OLP) Post-Approval Registry
Completed NCT05087550 - Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation
Recruiting NCT04836923 - LIFT Intervention in Liver Transplant Candidates N/A
Not yet recruiting NCT03666689 - Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation
Not yet recruiting NCT06088758 - Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool N/A
Terminated NCT01230502 - Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation N/A
Completed NCT00171509 - Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients Phase 4
Not yet recruiting NCT06254248 - Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma Phase 2
Recruiting NCT06075745 - Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates Phase 2
Not yet recruiting NCT06280950 - Expanding Liver Transplant Immunosuppression Minimization Via Everolimus Phase 2
Completed NCT02057484 - A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
Active, not recruiting NCT03577431 - Liver Transplantation With Tregs at MGH Phase 1/Phase 2
Recruiting NCT06342557 - Transitional ePRO Diary Liver
Not yet recruiting NCT04265157 - Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant